Abstract
The mapping of 5-HT2 receptors in the brain using functional imaging techniques has been limited by a relative lack of selective radioligands. Iodine-123 labelled 4-amino-N-[1-[3-(4-fluorophenoxy)propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide (123I-5-I-R91150 or123I-R93274) is a new ligand for single-photon emission tomography (SPET), with high affinity and selectivity for 5-HT2A receptors. This study reports on preliminary123I-5-I-R91150 SPET, wholebody and blood distribution findings in five healthy human volunteers. Maximal brain uptake was approximately 2% of total body counts at 180 min post injection (p.i.). Dynamic SPET sequences were acquired with the brain-dedicated, single-slice multi-detector system SEM-810 over 200 min p.i. Early peak uptake (at 5 min p.i.) was seen in the cerebellum, a region free from 5HT2A receptors. In contrast, radioligand binding in the frontal cortex increased steadily over time, up to a peak at approximately 100–120 min p.i. Frontal cortex-cerebellum activity ratios reached values of 1.4, and remained stable from approximately 100 min p.i. onwards. Multi-slice SPET sequences showed a pattern of regional variation of binding compatible with the autoradiographic data on the distribution of 5-HT2A receptors in (cerebral cortex>striatum>cerebellum). These findings suggest that123I-5-I-R91150 may be used for the imaging of 5-HT2A receptors in the living human brain with SPET.
Similar content being viewed by others
References
Cowen P. Serotonin receptor subtypes: implications for psychopharmacology.Br J Psychiatry 1991; 159 Suppl 12: 7–14
Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN. 5-HT2 receptor changes in major depression.Biol Psychiatry 1988, 27: 489–496
Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.Arch Gen Psychiatry 1993; 50: 810–818
Sargent T, Kalbhen DA, Shulgin AT, Braun G, Stauffer H, Kusubov N. In vivo human pharmacodynamics of the psychodysleptic 4-Br-2.5-dimethoxyphenylisopropylamine labelled with82Br or77Br.Neuropharmacology 1975; 14: 165–174
Stocklin G. Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.Eur J Nucl Med 1992; 19: 527–551
Sadzot B, Lemaire C, Maquet P, Salmon E, Plenevaux A, Degueldre C, Hermanne JP, Guillaume M, Cantineau R, Comar D, Franck G. Serotonin 5-HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.J Cereb Blood Flow Metab 1995; 15: 787–797.
Lundkvist C, Halldin C, ginovart N, Nyberg S, Swahn C-G, Carr AA, Brunner F, Farde L. [11C]MDL 100907, a radioligand for selective imaging of 5-HT2A receptors with positron emission tomography.Life Sci 1996; 58: 187–192
D'haenen H, Bossuyt A, Mertens J, Piron C, Gysemans M, Kaufman L. SPECT imaging of serotonin2 receptors in depression.Psychiatry Res 1992; 45: 227–237
Mertens J, Terriere D, Sipido V, Gommeren W, Janssen PMF, Leysen JE. Radiosynthesis of a new radioiodinated ligand for serotonin-5HT2-receptors, a promising tracer for γ-emission tomography.J Labelled Compounds Radiopharmaceuticals 1994; 34: 795–806
Terriere D, Janssen PMF, Gommeren W, Gysemans M, Mertens JJR, Leysen JE. Evaluation of radioiodo-4-amino-N-[1-[3-(4-fluorophenoxy)-propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide as a potential 5-HT2 receptor tracer for SPE(C)T.Nucl Med Biol 1995; 22: 1005–1010.
Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors.Neuroscience 1987; 21: 123–139
Abi-Dargham A, Terriere D, Zea-Ponce Y, Al-Tikriti M, Baldwin R, Hoffer D, Charney D, Laruelle M, Leysen JE, Innis R, Mertens J. [123I]5-I-R91150: a new SPECT tracer for the serotonin 5HT2A receptors.J Nucl Med 1995; 36: 164P.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Busatto, G.F., Pilowsky, L.S., Costa, D.C. et al. Initial evaluation of123|-5-|-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. Eur J Nucl Med 24, 119–124 (1997). https://doi.org/10.1007/BF02439542
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02439542